Filter
786
Text search:
specimen
transport
Featured
Recommendations
136
New Publications
251
Language
Document type
No document type
443
Guidelines
182
Manuals
56
Studies & Reports
51
Strategic & Response Plan
28
Training Material
12
Fact sheets
8
Situation Updates
4
Infographics
1
Videos
1
Countries / Regions
India
60
Kenya
34
Sierra Leone
27
Liberia
27
South Africa
27
Nigeria
24
Ethiopia
20
Ghana
19
Global
18
Namibia
16
Rwanda
15
Tanzania
14
Malawi
14
Uganda
13
Congo, Democratic Republic of
11
Philippines
9
Zambia
9
Bangladesh
9
Lesotho
9
Western and Central Europe
9
Nepal
8
Africa
8
West and Central Africa
7
Eastern Europe
6
Guinea
5
Zimbabwe
5
Myanmar / Burma
5
East and Southern Africa
5
Latin America and the Carribbean
5
South Sudan
4
Eastern Europe and Central Asia
4
Mali
3
Pakistan
3
Mozambique
3
Botswana
3
South–East Asia Region
3
Western Pacific Region
3
Senegal
2
Côte d’Ivoire / Ivory Coast
2
Togo
2
Haiti
2
Syria
2
Gambia
2
Eswatini/ Swaziland
2
Burundi
2
Angola
2
Russia
2
Burkina Faso
1
Guinea-Bissau
1
USA
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Afghanistan
1
Germany
1
Chad
1
Thailand
1
Indonesia
1
Mauritania
1
Central African Republic
1
Brazil
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Asia
1
Palestine
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Georgia
1
France
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
333
Clinical Guidelines
97
Pharmacy & Technologies
52
Public Health
32
Key Resources
25
Women & Child Health
14
Capacity Building
11
Toolboxes
TB
102
COVID-19
101
Ebola & Marburg
67
Rapid Response
52
HIV
38
NTDs
34
2.0 Rapid Response
26
Cholera
17
AMR
15
Malaria
12
Polio
9
Pharmacy
9
Natural Hazards
8
Zika
8
Caregiver
8
Mental Health
6
Conflict
4
Refugee
4
Planetary Health
3
Specific Hazards
2
Health Financing Toolbox
2
NCDs
2
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi
...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI
...
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u
...
Household transmission investigation protocol for 2019-novel coronavirus (2019-nCoV) infection
recommended
The household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-nCoV infection (see 2.2 Study population). It is intended to provide rapid and early information on the clinical, epidemiological and virological chara
...
Respiratory sample collection for Influenza and other respiratory viruses diagnosis - Infographic
Improve identification, verification, communication and coordination.
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level
...
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
The dashboard is based on assessments made by the International Preparedness Strengthening missions to 14 priority countries against each of the activities outlined in the WHO EVD Checklist at the time of each mission. Updates indicating progress against each of the indicators will be added on an o
...
